Cargando…
Hypoimmune induced pluripotent stem cell–derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice
The emerging field of regenerative cell therapy is still limited by the few cell types that can reliably be differentiated from pluripotent stem cells and by the immune hurdle of commercially scalable allogeneic cell therapeutics. Here, we show that gene-edited, immune-evasive cell grafts can surviv...
Autores principales: | Deuse, Tobias, Tediashvili, Grigol, Hu, Xiaomeng, Gravina, Alessia, Tamenang, Annika, Wang, Dong, Connolly, Andrew, Mueller, Christian, Mallavia, Beñat, Looney, Mark R., Alawi, Malik, Lanier, Lewis L., Schrepfer, Sonja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285900/ https://www.ncbi.nlm.nih.gov/pubmed/34244428 http://dx.doi.org/10.1073/pnas.2022091118 |
Ejemplares similares
-
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized mice
por: Hu, Xiaomeng, et al.
Publicado: (2023) -
Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression
por: Gravina, Alessia, et al.
Publicado: (2023) -
The SIRPα–CD47 immune checkpoint in NK cells
por: Deuse, Tobias, et al.
Publicado: (2021) -
MIS-C: A COVID-19-as sociated condition between hypoimmunity and hyperimmunity
por: Gelzo, Monica, et al.
Publicado: (2022) -
Transfusion of Human Platelets Treated with Mirasol Pathogen Reduction Technology Does Not Induce Acute Lung Injury in Mice
por: Caudrillier, Axelle, et al.
Publicado: (2015)